Dysbiosis and Links of the Middle Ear, Nasal, and Oral Microbiota in Chronic Otitis Media with Effusion

Abstract

Chronic otitis media with effusion (COME) is a common condition that can lead to hearing loss without acute inflammation. However, its underlying pathogenesis remains poorly understood, particularly with regard to microbial contributions. In this study, we characterized and compared the microbiota of the middle ear, nasal cavity, and oral cavity in 100 patients with COME and 77 controls using 16S rRNA gene sequencing. Alpha diversity, assessed by the Pielou index, was significantly reduced in the middle ear microbiota of COME patients compared with controls, and microbial compositions differed markedly across all sampled sites. Notably, Aeromonas, Serratia, and Lactococcus were enriched in both middle ear and nasal samples from COME patients. Among these, Aeromonas achieved the highest predictive value for COME in otic samples, whereas Lactococcus showed the strongest performance in nasal samples, with strong inter-site correlations. Functional analysis revealed the enrichment of pathways related to biofilm formation and depletion of antibiotic biosynthesis in COME-associated microbiota. These findings highlight the presence of microbial dysbiosis, particularly the interplay between nasal and middle ear microbiota, as a potential contributor to the COME pathogenesis, and suggest novel microbial targets for diagnosis and therapeutic intervention.

Keywords

chronic otitis media with effusion / microbial dysbiosis / middle ear microbiota / nasal microbiota / oral microbiota / 16S rRNA sequencing

References

[1] P. Shekelle, G. Takata, L. S. Chan, et al., “Diagnosis, Natural History, and Late Effects of Otitis Media with Effusion,” Evidence Report/Technology Assessment (Summary) no. 55 (2022): 1–5.

[2] N. Principi, P. Marchisio, and S. Esposito, “Otitis media With Effusion: Benefits and Harms of Strategies in Use for Treatment and Prevention,” Expert Review of Anti-Infective Therapy 14, no. 4 (2026): 415–423.

[3] P. Vanneste and C. Page, “Otitis media With Effusion in Children: Pathophysiology, Diagnosis, and Treatment. A Review,” Journal of Otology 14, no. 2 (2019): 33–39.

[4] F. Folino, L. Ruggiero, P. Capaccio, et al., “Upper Respiratory Tract Microbiome and Otitis Media Intertalk: Lessons From the Literature,” Journal of Clinical Medicine 9, no. 9 (2020): 2845.

[5] Y. Belkaid and T. W. Hand, “Role of the Microbiota in Immunity and Inflammation,” Cell 157, no. 1 (2014): 121–141.

[6] D. Kim, M. Y. Zeng, and G. Núñez, “The Interplay Between Host Immune Cells and Gut Microbiota in Chronic Inflammatory Diseases,” Experimental & Molecular Medicine 49, no. 5 (2017): e339.

[7] C. C. Ngo, H. M. Massa, R. B. Thornton, et al., “Predominant Bacteria Detected From the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review,” PLoS ONE 11, no. 3 (2016): e0150949.

[8] C. M. Liu, M. K. Cosetti, M. Aziz, et al., “The Otologic Microbiome: A Study of the Bacterial Microbiota in a Pediatric Patient With Chronic Serous Otitis media Using 16SrRNA Gene-Based Pyrosequencing,” Archives of Otolaryngology-Head and Neck Surgery 137, no. 7 (2011): 664–668.

[9] J. Jervis-Bardy, G. B. Rogers, P. S. Morris, et al., “The Microbiome of Otitis Media with Effusion in Indigenous Australian Children,” International Journal of Pediatric Otorhinolaryngology 79, no. 9 (2015): 1548–1555.

[10] C. L. Chan, D. Wabnitz, J. J. Bardy, et al., “The Microbiome of Otitis Media with Effusion,” Laryngoscope 126, no. 12 (2016): 2844–2851.

[11] Y. Fan, J. Chen, S. Xu, et al., “Bacillus Cereus Is a Key Microbial Determinant of Intractable Otitis Media with Effusion,” Communications Medicine (London) 5, no. 1 (2025): 150.

[12] A. R. Kolbe, E. Castro-Nallar, D. Preciado, et al., “Altered Middle Ear Microbiome in Children with Chronic Otitis Media with Effusion and Respiratory Illnesses,” Frontiers in Cellular and Infection Microbiology 9 (2019): 339.

[13] J. Xu, W. Dai, Q. Liang, et al., “The Microbiomes of Adenoid and Middle Ear in Children with Otitis Media With Effusion and Hypertrophy from a Tertiary Hospital in China,” International Journal of Pediatric Otorhinolaryngology 134 (2020): 110058.

[14] A. Luong and P. S. Roland, “The Link Between Allergic Rhinitis and Chronic Otitis Media With Effusion in Atopic Patients,” Otolaryngologic Clinics of North America 41, no. 2 (2008): 311–323.

[15] E. Kreiner-Møller, B. L. K. Chawes, P. Caye-Thomasen, et al., “Allergic Rhinitis Is Associated with Otitis Media with Effusion: A Birth Cohort Study,” Clinical & Experimental Allergy 42, no. 11 (2012): 1615–1620.

[16] C. Cingi, P. Gevaert, R. Mösges, et al., “Multi-Morbidities of Allergic Rhinitis in Adults: European Academy of Allergy and Clinical Immunology Task Force Report,” Clinical and Translational Allergy 7 (2017): 17.

[17] M. Daval, H. Picard, E. Bequignon, et al., “Chronic Otitis media With Effusion in Chronic Sinusitis With Polyps,” Ear, Nose & Throat Journal 97, no. 8 (2018): E13–E18.

[18] G. Brescia, A. Frosolini, L. Franz, et al., “Chronic Otitis Media in Patients with Chronic Rhinosinusitis: A Systematic Review,” Medicina (Kaunas, Lithuania) 59, no. 1 (2023): 123.

[19] M. Formánek, K. Zeleník, P. Komínek, et al., “Diagnosis of Extraesophageal Reflux in Children With Chronic Otitis Media With Effusion Using Peptest,” International Journal of Pediatric Otorhinolaryngology 79, no. 5 (2015): 677–679.

[20] M. Karyanta, S. Satrowiyoto, and D. P. Wulandari, “Prevalence Ratio of Otitis Media With Effusion in Laryngopharyngeal Reflux,” International Journal of Otolaryngology 2019 (2019): 7460891.

[21] H. Byeon, “The Association Between Allergic Rhinitis and Otitis media: A National Representative Sample of in South Korean Children,” Scientific Reports 9, no. 1 (2019): 1610.

[22] Y. J. Kim, H. W. Jung, Y.-S. Choi, et al., “Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children With Otitis Media Effusion in Korea,” Clinical Laboratory 68, no. 1 (2022).

[23] S. K. Kim, S. J. Hong, K. H. Pak, et al., “Analysis of the Microbiome in the Adenoids of Korean Children with Otitis Media With Effusion,” The Journal of International Advanced Otology 15, no. 3 (2019): 379–385.

[24] R. E. Walker, C. G. Walker, C. A. Camargo, et al., “Nasal Microbial Composition and Chronic Otitis Media With Effusion: A Case-Control Study,” PLoS ONE 14, no. 2 (2019): e0212473.

[25] O. Sokolovs-Karijs, M. Brīvība, R. Saksis, et al., “Comparing the Microbiome of the Adenoids in Children With Secretory Otitis Media and Children Without Middle Ear Effusion,” Microorganisms 12, no. 8 (2024): 1523.

[26] S. B. Minami, H. Mutai, T. Suzuki, et al., “Microbiomes of the Normal Middle Ear and Ears with Chronic Otitis Media,” Laryngoscope 127, no. 10 (2017): E371–E377.

[27] J.-Y. Lee, K. M. Jacob, K. Kashefi, et al., “Oral Seeding and Niche-Adaptation of Middle Ear Biofilms in Health,” Biofilm 3 (2021): 100041.

[28] G. P. Buzatto, E. Tamashiro, J. L. Proenca-Modena, et al., “The Pathogens Profile in Children with Otitis Media With Effusion and Adenoid Hypertrophy,” PLoS ONE 12, no. 2 (2017): e0171049.

[29] A. Fernández-Bravo and M. J. Figueras, “An Update on the Genus Aeromonas: Taxonomy, Epidemiology, and Pathogenicity,” Microorganisms 8, no. 1 (2020): 129.

[30] E. Talagrand-Reboul, E. Jumas-Bilak, and B. Lamy, “The Social Life of Aeromonas Through Biofilm and Quorum Sensing Systems,” Frontiers in Microbiology 8 (2017): 37.

[31] P.-L. Chen, W.-C. Ko, and C.-J. Wu, “Complexity of β-Lactamases Among Clinical Aeromonas Isolates and Its Clinical Implications,” Immunology and Infection 45, no. 6 (2012): 398–403. Journal of Microbiology.

[32] S. D. Mahlen, “Serratia Infections: From Military Experiments to Current Practice,” Clinical Microbiology Reviews 24, no. 4 (2011): 755–791.

[33] F. Uddén, M. Filipe, Å. Reimer, et al., “Aerobic Bacteria Associated With Chronic Suppurative Otitis Media in Angola,” Infectious Diseases of Poverty 7, no. 1 (2018): 42.

[34] A. Shimizu, R. Hase, D. Suzuki, et al., “Lactococcus lactis Cholangitis and Bacteremia Identified by MALDI-TOF Mass Spectrometry: A Case Report and Review of the Literature on Lactococcus lactis Infection,” Journal of Infection and Chemotherapy 25, no. 2 (2019): 141–146.

[35] A. S. Laufer, J. P. Metlay, J. F. Gent, et al., “Microbial Communities of the Upper Respiratory Tract and Otitis Media in Children,” MBio 2, no. 1 (2011): e00245–e00210.

[36] Human Microbiome Project Consortium. “Structure, Function and Diversity of the Healthy Human Microbiome,” Nature 486, no. 7402 (2012): 207–214.

[37] B. M. Prüß, “Involvement of Two-Component Signaling on Bacterial Motility and Biofilm Development,” Journal of Bacteriology 199, no. 18 (2017): e00259–e00317.

[38] L. Houot, S. Chang, B. S. Pickering, et al., “The Phosphoenolpyruvate Phosphotransferase System Regulates Vibrio Cholerae Biofilm Formation Through Multiple Independent Pathways,” Journal of Bacteriology 192, no. 12 (2010): 3055–3067.

[39] M. Jiang, Y.-B. Su, J.-Z. Ye, et al., “Ampicillin-controlled Glucose Metabolism Manipulates the Transition From Tolerance to Resistance in Bacteria,” Science Advances 9, no. 10 (2023): eade8582.

[40] V. Palma, M. S. Gutiérrez, O. Vargas, et al., “Methods to Evaluate Bacterial Motility and Its Role in Bacterial-Host Interactions,” Microorganisms 10, no. 3 (2022): 563.

[41] A. Jotic, K. Savic Vujovic, and A. Cirkovic, “Antibiofilm Effects of Novel Compounds in Otitis Media Treatment: Systematic Review,” International Journal of Molecular Sciences 25, no. 23 (2024): 12841.

[42] C. E. Armbruster and W. E. Swords, “Interspecies Bacterial Communication as a Target for Therapy in Otitis media,” Expert Review of Anti-Infective Therapy 8, no. 10 (2010): 1067–1070.

[43] M. Neeff, K. Biswas, M. Hoggard, et al., “Molecular Microbiological Profile of Chronic Suppurative Otitis Media,” Journal of Clinical Microbiology 54, no. 10 (2016): 2538–2546.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.